Cargando…
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
There is urgent need for the development of mechanistically different and less side-effect prone antipsychotic compounds. The endocannabinoid system has been suggested to represent a potential new target in this indication. While the chronic use of cannabis itself has been considered a risk factor c...
Autores principales: | Rohleder, Cathrin, Müller, Juliane K., Lange, Bettina, Leweke, F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099166/ https://www.ncbi.nlm.nih.gov/pubmed/27877130 http://dx.doi.org/10.3389/fphar.2016.00422 |
Ejemplares similares
-
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
por: Leweke, F. Markus, et al.
Publicado: (2021) -
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
por: Woelfl, Timo, et al.
Publicado: (2020) -
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state
por: Koethe, Dagmar, et al.
Publicado: (2023) -
Case Report: Severe Adolescent Major Depressive Syndrome Turns Out to Be an Unusual Case of Anti-NMDA Receptor Encephalitis
por: Moldavski, Alexander, et al.
Publicado: (2021) -
Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review
por: Couttas, Timothy A., et al.
Publicado: (2022)